HEALTH CATALYST INC - NOTE 2.500% 4/1

CUSIP: 42225TAB3

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Debt / NOTE 2.500% 4/1
Market price (% of par)
96.19%
Total 13F principal
$210,375,626
Principal change
-$35,000
Total reported market value
$220,007,851
Number of holders
14
Value change
-$2,767,941
Number of buys
4
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 42225TAB3?
CUSIP 42225TAB3 identifies 42225TAB3 - HEALTH CATALYST INC - NOTE 2.500% 4/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HEALTH CATALYST INC - NOTE 2.500% 4/1 as of Q3 2023

As of 30 Sep 2023, HEALTH CATALYST INC - NOTE 2.500% 4/1 was held by 14 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $210,375,626 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, TENOR CAPITAL MANAGEMENT Co., L.P., LAZARD ASSET MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Opti Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Kohlberg Kravis Roberts & Co. L.P., and PIER 88 INVESTMENT PARTNERS LLC. This page lists 14 institutional bondholders reporting positions for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.